Radical Pathways in Electrodes Offer Precision Weapon Against Paracetamol-Laden Wastewater
Preprint uses EPR to quantify radicals on novel electrode for faster paracetamol degradation; BDD anode outperforms Pt in lab tests, with broader implications for targeted pharmaceutical wastewater treatment amid environmental persistence concerns.
A June 2026 arXiv preprint (not yet peer-reviewed) details how Electron Paramagnetic Resonance spectroscopy directly measured hydroxyl and aryl radicals on a NaNbO3@CeO2-modified carbon gas diffusion electrode during paracetamol breakdown. The lab-scale setup compared boron-doped diamond versus platinum anodes in controlled aqueous solutions, achieving full degradation in 15 minutes with the BDD configuration versus 45 minutes for platinum, alongside 81.6% versus 67.8% mineralization. This moves beyond earlier indirect radical inferences in electro-Fenton literature by quantifying species in real time. The work highlights how BDD anodes shift radical ratios (65% OH, 35% aryl) to accelerate aryl-ring cleavage in the common analgesic, a pollutant now routinely detected in rivers and treatment plant effluents worldwide. Related studies, such as those in Water Research on advanced oxidation processes for pharmaceuticals, show similar compounds persist through conventional plants and may promote antibiotic resistance genes, while a 2023 Environmental Science & Technology paper on CeO2 catalysts underscores oxygen-vacancy effects that this electrode appears to amplify. Limitations include the absence of real-matrix wastewater testing, unknown long-term electrode stability, and no reported replicate counts or statistical power analysis typical of scaled engineering trials. The findings suggest electrode design can be tuned to specific radical profiles rather than generic oxidation, potentially cutting energy costs for micropollutant removal but requiring field validation before municipal adoption.
HELIX: Direct radical quantification could shift electro-Fenton design from trial-and-error to pathway-specific optimization, though real-world scaling remains untested.
Sources (3)
- [1]Primary Source(https://arxiv.org/abs/2606.10034)
- [2]Related Source(https://doi.org/10.1016/j.watres.2022.118567)
- [3]Related Source(https://doi.org/10.1021/acs.est.3c01234)